Change Location × Toronto

    Recent Locations

      Canada Meetings on Computer Aided Drug Designing and Drug Delivery (CSE) in Toronto

      • Canada Meetings on Computer Aided Drug Designing and Drug Delivery (CSE) Photo #1
      1 of 1
      September 27, 2019

      Friday   8:00 AM

      Venue will be informed to the Registered Participants
      Toronto, Ontario

      • No Performers Listed
      Canada Meetings on Computer Aided Drug Designing and Drug Delivery (CSE)

      Canada Meetings on Computer Aided Drug Designing and Drug Delivery About OverviewCanada Meetings on Computer Aided Drug Designing and Drug Delivery 2019CADD and Drug Delivery 2019 is once again pleased to support scientific research in the field of drug development and drug delivery.The “Canada Meetings on Computer Aided Drug Designing and Drug Delivery” brings together leading drug development and drug delivery scientists from both industry and academia to share and discuss their latest work.We feel proud to present the highly anticipated Canada Meetings on Computer Aided Drug Designing and Drug Delivery to be held on 27-28 September 2019, Toronto, Canada.The conference programme consists of world-class keynote addresses, industry-led presentations, as well as extensive networking opportunities, creating an interactive platform for high-level scientific and business discussions. This event covering the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships.The program agenda is stuffed with selected talks on topics related to drug development and drug delivery.Key benefits of attending:    Learn about the latest drug delivery technology solutions for both small and large molecule drugs.    Network with key decision makers from pharmaceutical, biotechnology, and medical device companies and explore areas for potential collaboration.    Discover the current drug delivery needs of pharma and biotech companies and determine what they are looking for in terms of external delivery technologies.    Understand the potential impact digital health applications and digitally-enabled drug delivery systems can have on improving patient adherence and overall health outcomes.Submit us your abstract here @ Abstract Submission.Key Sessions/TracksTrack 1: Computer Aided Drug Designing    Ligand and structure based drug design    Computational Chemistry    Molecular modelling    Enzyme as target    Receptor as target    QSAR/QSPR Quantitative structure activity/property relationships    Track 2 : Advances in Drug Delivery    Novel Drug Delivery Systems    Routes of Drug Administration    Delivery of new therapeutic modalities    Delivery of emerging biologics including mRNA, siRNA delivery, DNA delivery    Vaccine Based Drug Delivery TechnologyTrack 3 : Drug Delivery Devices    Needle-free delivery systems    Patient centered integrated device implementation    Devices development - continuous administration of drugs    Human Factors, Behavioural Design And Human Centred Design For Delivery Device DevelopmentTrack  4 : Advancements in Drug Designing    GPCR-Targeted Drug Design    Lead Optimization for Drug Metabolism and SafetyTrack 5: Novel Drug Discovery and Drug Delivery    Role of computational biology    Pioneering digital health and smart drug delivery systems    Ligand binding studies    Phage display technology for clinical application of protein drugsTrack 6: Large Molecule Drug Formulation    Protein-Protein Interactions    Inflammation and Autoimmune Inhibitors    Kinase Inhibitor Chemistry    Vaccines, Antibodies, Biotherapeutics    Formulation development for biosimilarsTrack 7: Bioanalysis and Stabilisation    Bioanalytical development for large molecules    Analytical development for novel therapeutics    Analytical strategies for novel proteins and antibodies    Stability testing and stability approaches for biologics    Understanding the characterisation of large molecules    Novel analytical tools to analyse particlesTrack 8: ADME    ADME (adsorption, distribution, metabolism and excretion)Of drugs    Metabolism and toxicology    Antiviral and antimicrobial activity    Drug receptor interaction    Kojic acid as a tyrosine inhibitorTrack 9:  Medicinal Chemistry and Drug Discovery    Target discovery and validation    Molecular modelling    Drug receptor interactions    Pro drug synthesis and drug targeting    Toxicity, and therapeutic applications of antibiotics, antifungals, and antiviralsTrack 10: Nanotechnology in Drug Delivery    Nanoparticles that deliver three anti-cancer drugs to the lymph nodes    Sustained drug delivery using a hydrogen    Photosensitizing agent to enhance the ability of drug carrying nanoparticles    Nanotechnology in Drug Delivery - Heart Disease    Carbon nanofibers penetrate diseased cells    Nanotechnology in Drug Delivery - Aging and other areasTrack 11:  Chem Virology    Rapid Transmission    ZIKV-Processing on the microfluidic cassette    ZIKA virus infection may prevent reinfection    Zika infection-A global threat to human population    Major possible symptoms     Drugs and vaccines available so farTrack 12:  Posology    Factors affecting the drug dosage    Route of AdministrationTrack 13:  Cancer Studies: Drug Delivery Chemistry    Magnetoelectric nanoparticles    Nanoparticle drug delivery    Problems of multidrug resistance in cancer therapies    Taxoids as potent cytotoxic agents for tumour targeting drug deliveryTrack 14: Drug Biotransformation and Disposition    High resolution-mass spectrometry (HR-MS) technology    Data-mining tools    AB SCIEX TripleTOF™ 5600 System for the study of drug metabolism in BDC rats and CYP inhibition cocktail assays.Track 15: Small Molecule Drug Formulation    Recent progress in amorphous solid dispersions    Advanced formulation strategies & methods for small molecules    Overcoming key formulation challenges for small molecules    Nano-formulations    Quality-by-Design approaches    Excipients for small molecule formulationTrack 16: Drug Delivery Systems    Drug Delivery Technologies    Drug Delivery Innovation AGENDA 2018------------------------------2019 Upcoming Soon------------------------------Day 1 September 24, 2018Conference Hall: Superior Ballroom BRegistrations08:30-08:55 Opening CeremonyKeynote Forum08:55-09:00 Introduction09:00-09:30 Title: Amyloid hypothesis and drug development for Alzheimer’s disorder: A critical reviewOleg V Tcheremissine, Atrium Health, USA09:30-10:00 Title: Multivalent polymer conjugate inhibits aggregation of ß amyloid anddisassembles amyloid fibrils – potential for a polymer therapeuticEdwin G Moore, University of Illinois, Urbana10:00-10:30 Title: Development and commercialization of oral peptide and protein therapeutics:Trends and perspectivesPanayiotis P Constantinides, Biopharmaceutical & Drug Delivery Consulting LLC, USAGroup Photo & Panel Discussion 10:30-10:40Networking and Refreshment Break 10:40-11:00 @ Foyer11:00-11:30 Title: Solutions for collaborative drug discovery – Connecting researchers globallyLuke S Fisher, Collaborative Drug Discovery, Inc., USA11:30-12:00 Title: Activating endocytosis for enhancing cellular delivery and modifying intracellulartargeting of therapeuticsArwyn T Jones, Cardiff University, UK12:00-12:30 Title: Pursuit of oral insulin is a reality: Is it simply a matter of when?Prakash V Diwan, National Institute of Pharmaceutical Education and Research, India12:30-13:00 Title: Minority populations in clinical trialsRodney Villanueva & Oleg V Tcheremissine, Atrium Health, USAPanel DiscussionLunch Break 13:00-14:00 @ MichiganWorkshop14:00-14:45 Title: Planning and submitting clinical trial applications to Ex US countriesSiddhartha Chowdhury, Northeastern University, USASessions: Drug Discovery and Development | Patient-Centric Clinical Trials | Polymer–PeptideConjugates | Medicinal Chemistry and Drug Discovery | Drug Delivery Systems | Patient-CentricClinical Trials | Globalization of Clinical TrialsSession Chair: Edwin G Moore, University of Illinois, UrbanaSession Chair: Panayiotis P Constantinides, Biopharmaceutical & Drug Delivery Consulting LLC, USASession Introduction14:45-15:05Title: Implementing strategic financial management for clinical researchBrandon Furr, Atrium Health, USA15:05-15:25Title: Total syntheses and their biological evaluation of poison-frog alkaloids ent-cis195Aand cis-211ANaoki Toyooka, University of Toyama, JapanPanel DiscussionNetworking and Refreshment Break 15:25-15:45 @ Foyer15:45-16:05Title: Magnetic nanoparticles: Application as RF hyperthermia therapy & contrast agentin magnetic resonance imagingBijoy K Kuanr, Jawaharlal Nehru University, India16:05-16:25 Title: The power of theory in developing the design of targeted nanoparticlesEbtisam A Aldaais, Imam Abdulrahman Bin Faisal University, Saudi Arabia16:25-16:45Title: Designing of inhibitors for cancer phenotype: An experimental and computationalapproachNavaneetha Nambigari, Osmania University, India16:45-17:05Title: Development of small-molecule antagonists for PAC1 receptor aimed at drugdiscovery of novel analgesicsTakuya Okada, University of Toyama, JapanPanel DiscussionNetworking & Business to Business Meeting 17:05-17:30Day 2 September 25, 2018Conference Hall: Superior Ballroom BKeynote Forum08:55-09:00 Introduction09:00-09:30 Title: The dog story: A patient’s perspective on research and healthcareMatt Cavallo, Patient Activation Network, USA09:30-10:00 Title: SBDD of MDM2 and β-secretase inhibitors using FMO and machine learningTatsuya Takagi, Osaka University, Japan10:00-10:30 Title: Modeling and simulation bring deep understandings of device drug delivery toimprove patient experienceGuiyong (Nick) Song, The University of Missouri, USAGroup Photo 10:30-10:40Networking and Refreshment Break 10:40-11:00 @ Foyer11:00-11:30     Title: Self administrative drug delivery devices made with plastics material – marketpotential, customer discovery, challenges, manufacturing, and business modelRahul R Panchal, Leonine Technologies Inc., USA11:30-12:00 Title: Wonders and worries of nano technology in health carePrakash V Diwan, Central Research Laboratory India12:00-12:30 Title: Simple is better in nanomedicineVinod Labhasetwar, Lerner Research Institute, USAPanel DiscussionLunch Break 12:30-13:30 @ MichiganSessions: Clinical Research & Clinical Trials | Computer Aided Drug Designing | Drug DeliverySystems| Nanotechnology in Drug Delivery | Clinical Trial Forecasting, Budgeting and Contracting|Drug Discovery and Development| Patient-Centric Clinical Trials| Clinical Trial Site Selection andManagement| Pharmaceutical Nanotechnology |Drug Delivery TechnologySession Chair: Arwyn T Jones, Cardiff University, UKSession Co-chair: Tatsuya Takagi, Osaka University, JapanSession Introduction13:30-13:50Title: Metformin prevents high glucose induced disruption of coronary artery endothelialbarrier function and accelerates wound healingMohammad Tauseef, Chicago State University, USA13:50-14:10 Title: Drug discovery research in academiaRama Mishra, Northern Western University, USA14:10-14:30Title: Computer analysis of the heterogeneous surfaces using the unique fast multivariantnumerical procedure with the new clustering based modelsMirosław Kwiatkowski, AGH University of Science and Technology, Poland14:30-14:50Title: Ruthenium (II) polypyridyl complexes: Investigation of DNA binding study andantiproliferative activityNavaneetha Nambigari, Osmania University, IndiaPage 414:50-15:10Title: Photodynamic mediated anticancer therapy using temoporfin (mthpc) loadedliposomesSajid Ali, Philipps University Marburg, Germany15:10-15:30 Title: Tribology in phantom pain in upper limb amputeesSedegheh Malek Mohammadi, Orthotics and Prosthetics Research Clinic, IranPanel DiscussionNetworking and Refreshment Break 15:30-15:50 @ Foyer15:50-16:10Title: Formulation and evaluation of mouth dissolving tablet of donepezil with superdisintegrantsRubina Fatima, MRM Collage of Pharmacy, India16:10-16:30Title: A comparative study of crude extracts from some medicinal plants against malariapathogens with chloroquine drugOchieng O Anthony, Sumait University, ZanzibarPoster Presentations 16:30-17:30Poster 01Title: Assessing the acceptability of N-of-1 trials/tests and their implementation: Gettingready for piloting N-of-1 trials in ethiopiaChalachew Alemayehu, University of Queensland, AustraliaPoster 02 Title: Enhanced inner ear drug delivery assisted by ultrasound-aided microbubblesChih-Hung Wang, National Defense Medical Center, TaiwanPoster 03Title: Study start up for a global phase III study: A case study on a global multicenterPhase III CNS studiesSiddhartha Chowdhury, Northeastern University, USAPoster 04Title: Overview of bioequivalence study methods with pharmacokinetics endpoint fortopical ophthalmic corticosteroid suspensions (ocs)Yoriko Harigaya, University at Buffalo, USAPoster 05 Title: Bioassay protocols: Semantic annotation to enable informaticsLuke S Fisher, Collaborative Drug Discovery, Inc., USAPoster 06 Title: Innovative approaches for secure, modern collaborative drug discoveryLuke S Fisher, Collaborative Drug Discovery, Inc., USAPoster 07Title: A new perspective for possible formulation and characterization of BetaCyclodextrin/Poly(ethyleneglycol) crystalline inclusion complexesAmal Abdulrahman, Clark Atlanta University, USAPanel DiscussionNetworking & Business to Business Meeting 17:30-17:45Day 3 September 26, 2018Conference Hall: Superior Ballroom BKeynote Forum09:30-10:00 Title: Biophysics of cell membrane lipids in cancer drug resistance: Drug transport anddrug delivery with nanoparticlesVinod Labhasetwar, Lerner Research Institute, USAExhibitors Session 10:00-10:50Panel DiscussionNetworking and Refreshment Break 10:50-11:10 @ FoyerSessions: Clinical Trial Forecasting, Budgeting and Contracting | Novel Drug Delivery Systems| DrugDelivery Technology | Pharmaceutical NanotechnologySession Chair: Prakash V Diwan, National Institute of Pharmaceutical Education and Research, IndiaSession Introduction11:10-11:30 Title: Advance microneedles integrated transdermal patch for fast onset of IvermectinRubina Fatima, MRM Collage of Pharmacy, India11:30-11:50Title: Lipid coated mesoporous silica nanoparticles for enhanced delivery and cellularuptake of doxorubicinMuhammad Umair Amin, Philipps University Marburg, GermanyPage 511:50-12:10Title: A comparison of quality of prescriptions at primary, secondary and tertiary healthcare facilities using prescription quality index toolJalpa V Suthara, Charotar University of Science and Technology, India12:10-12:30 Title: Fair market value and grant plan: Tool for negotiating clinical trial site budgetsSiddhartha Chowdhury, Northeastern University, USA12:30-12:50Title: Endoscopy assisted laparoscopic resection of benign colonic polyps; a retrospectivestudy on safe approach to complete removalSaad Ikram, Scunthorpe General Hospital, United KingdomPanel DiscussionsLunch Break- 12:50-13:50 @ Ontario13:50-14:10Title: Active metabolites of the marine strain Streptomyces sundarbansensis with highestand selective antibacterial activity against MRSAMouloud Kecha, University of Bejaia, Algeria14:10-14:30 Title:Aala Ali Abdulrahim, University of Khartoum, SudanVideo Presentation14:30-14:50Title: Transdermal Delivery of Pravastatin Loaded Microemulsion Based, Drug DeliverySystem Developed By Central Composite DesignAnjali Devi Nippani, Kakatiya University, IndiaPanel DiscussionsNetworking & Business to Business Meeting 14:50-15:20 @ FoyerAwards & Closing Cermony Please contact the event manager Marilyn (marilyn.b.turner(at) ) below for:- Multiple participant discounts- Price quotations or visa invitation letters- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)- Event sponsorshipNO REFUNDS ALLOWED ON REGISTRATIONSPrices may go up any time. Service fees included in pricing.-----------------------------------------------------------------This event is brought to you by:Conference Series - NewYorkEventsListhttp://www.NyEventsList.comhttp://www.BostonEventsList.com VIO181109CRE

      Categories: Business & Networking | Technology

      Event details may change at any time, always check with the event organizer when planning to attend this event or purchase tickets.